Recombinant Human Anti-TSHR Antibody (M22)

Recombinant Human Antibody (M22) is capable of binding to TSHR, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-TSHR mAb and CH1-3 region of human IgG and a light chain (LC) encoding VL from anti- TSHR proteins mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition. A human monoclonal autoantibody to the TSHR (M22), which is a powerful thyroid stimulator with high affinity for the receptor, and determined its crystal structure at 1.65A° resolution. It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.

Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.

Key Features / Benefits

• productname: Recombinant Human Anti-TSHR Antibody (M22)
• abbr: Recombinant Anti-TSHR Antibody (M22)
• Target: TSHR
• Host Animal: Human
• Specificity: Tested positive against native TSHR
• Immunogen: Human thyroid stimulating hormone receptor

Relevant Applications

• WB
• ELISA
• PK
• The TSHR antibody has been reported in applications of Western Blot
• Enzyme-linked Immunosorbent Assay
• Pharmacokinetic.